Horizon Therapeutics Shares Surge As FTC Postpones Challenge to Merger
- Investing News
admin
- 0
- 1 minute read
Horizon Therapeutics shares jumped more than 5% early trading Monday after the FTC said it would suspend its challenge to Amgen’s acquisition of the drug maker.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2173588208-8c8f22f916ad46719d9aff854e35bd97.jpg "Should You Work at a Boutique Investment Bank?")
